New nerve block may cut opioid use after gallbladder surgery
NCT ID NCT07276646
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests two different nerve blocks to see which one better reduces pain and the need for strong painkillers after laparoscopic gallbladder removal. Eighty adults having elective surgery will be randomly assigned to receive one of the two blocks. The main goal is to see how long it takes before they need extra pain medication.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- nerve block procedure (retrosuperior costotransverse ligament block or erector spinae block)
- What this could lead to
- If successful, this could identify a better nerve block technique to reduce opioid use and improve pain control after gallbladder surgery.
- What could go wrong
- This is a small, early-phase study (80 participants) comparing two established techniques, so any advantage may be modest or not apply to other surgeries or patient groups.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 80 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Dec 2025
- Expected to finish
-
Jul 2026
An estimate. End dates often move.
- Lead sponsor
-
A government agency
The lead sponsor is a government body.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
21 to 64 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. patient acceptance 2. Age: 21-64 years old. 3. Sex: both sexes. 4. Physical status: ASA I \& II. 5. Body mass index (BMI): 18.5 - 30 kg/m2. 6. Type of operations: elective laparoscopic cholecystectomy. 7. Duration of surgery not more than 2 hours. Exclusion Criteria: 1. Known hypersensitivity to lidocaine or bupivacaine. 2. Patients with respiratory insufficiency. 3. Coagulation disorders or taking drugs affect surgical hemostasis. 7\. Patients with pre-existing neurological deficits. 8. Uncooperative patient or with altered mental status. 9. Patient with advanced cardiovascular or respiratory diseases
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Perioperative analgesia are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Faculty of human medicine, Zagazig university, Zagazig
RECRUITINGZagazig, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a targeted nerve block replace opioids for chemoport surgery?
- Nerve blocks may slash opioid use after heart surgery
- Painkiller form may matter after gastric bypass
- New study aims to cut opioid use in gallbladder surgery with targeted nerve blocks
- New combo could ease back surgery pain without opioids
- New nerve block slashes opioid use in kidney stone surgery